Company / Interest Expense per Share
Veracyte, Inc. Interest Expense per Share History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2020
5-year range
-
FY2016-FY2020
Trend
-72.1%
vs FY2019
Sector context
#39 of 40
Health Care
What the data says
Among 40 Health Care companies, Veracyte, Inc. is in the top 3% for interest expense per share. Interest Expense per Share has declined for 3 consecutive years, from $0.15 in FY2017 to $0.00 in FY2020.
Based on SEC 10-K filings.
0.00 in FY2020 with a 3-year CAGR of -68.4%.
Improved from $0.06 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -68.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 40This company $0.00 Sector average $1.56
▼
-99.7% below sector average
Key checks
Key Insights
- Veracyte, Inc.'s interest expense per share has declined for 3 consecutive years.
- In FY2020, interest expense per share decreased 72.1% year-over-year.
- Ranks #39 out of 40 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.00 | -72.1% |
| FY2019 | $0.02 | -71.5% |
| FY2018 | $0.06 | -60.3% |
| FY2017 | $0.15 | +47.0% |
| FY2016 | $0.10 | +493.4% |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026